In a sector of constant innovation, a company must be something special if even the experts are excited. These are the four ...

Pharmaceutical stock Gilead Sciences Inc (NASDAQ:GILD) is down 2.6% at $107.34, after news that domestic HIV prevention is ...

By Samantha [email protected] The Antigua Planned Parenthood Association (APPA) hosted a community health day at the Mack Pond football ...

Gilead stock tumbled Wednesday on reports HHS could slash federal funding for HIV prevention, a staple in Gilead Sciences' ...

We suggest that investors who own GSK's stock remain invested for now, considering its sales and profits are expected to continue improving in the coming years.

March is Human Rights Month, and last week, we commemorated this day in the Eastern Cape. As South Africans, we were reminded of where we come from, and the prize paid for our freedom. This day was ...

Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $90 ...

When it comes to antibiotic stewardship and clinical care, Brad Spellberg, MD, just wants to see the data.

Gilead Sciences has been one of the best-performing large biotech companies over the past year, rising about 50%. That is ...

People with AIDS also have HIV, as HIV is the first stage of AIDS. Learn about the differences, how the conditions overlap, ...

There could be 2,000 new HIV infections a day across the world and a ten-fold increase in related deaths if funding frozen by ...